PHS
AERI

PFM Health Sciences’s Aerie Pharmaceuticals, Inc. AERI Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-699,531
Closed -$5.25M 88
2022
Q2
$5.25M Sell
699,531
-389,035
-36% -$2.92M 0.2% 70
2022
Q1
$9.91M Hold
1,088,566
0.37% 52
2021
Q4
$7.64M Sell
1,088,566
-1,094,118
-50% -$7.68M 0.26% 57
2021
Q3
$24.9M Hold
2,182,684
0.73% 41
2021
Q2
$34.9M Buy
2,182,684
+115,000
+6% +$1.84M 1.1% 35
2021
Q1
$37M Sell
2,067,684
-159,927
-7% -$2.86M 1.13% 28
2020
Q4
$30.1M Hold
2,227,611
1.06% 30
2020
Q3
$26.2M Sell
2,227,611
-46,609
-2% -$549K 1.21% 29
2020
Q2
$33.6M Sell
2,274,220
-254,056
-10% -$3.75M 1.74% 17
2020
Q1
$34.1M Buy
2,528,276
+114,812
+5% +$1.55M 2.8% 13
2019
Q4
$58.3M Buy
2,413,464
+582,540
+32% +$14.1M 2.78% 9
2019
Q3
$35.2M Buy
+1,830,924
New +$35.2M 1.04% 34
2019
Q1
Sell
-1,893,935
Closed -$68.4M 117
2018
Q4
$68.4M Sell
1,893,935
-364,508
-16% -$13.2M 1.82% 21
2018
Q3
$139M Sell
2,258,443
-461,775
-17% -$28.4M 2.04% 4
2018
Q2
$184M Sell
2,720,218
-112,785
-4% -$7.62M 2.88% 3
2018
Q1
$154M Buy
2,833,003
+225,792
+9% +$12.2M 3.12% 5
2017
Q4
$156M Buy
2,607,211
+193,750
+8% +$11.6M 3.69% 3
2017
Q3
$117M Buy
2,413,461
+665,421
+38% +$32.3M 2.3% 4
2017
Q2
$91.9M Buy
1,748,040
+454,911
+35% +$23.9M 2.47% 6
2017
Q1
$58.6M Sell
1,293,129
-142,626
-10% -$6.47M 1.47% 24
2016
Q4
$54.3M Sell
1,435,755
-530,662
-27% -$20.1M 1.53% 19
2016
Q3
$74.2M Sell
1,966,417
-375,223
-16% -$14.2M 2.17% 11
2016
Q2
$41.2M Sell
2,341,640
-39,495
-2% -$695K 1.24% 30
2016
Q1
$29M Buy
2,381,135
+6,338
+0.3% +$77.1K 0.89% 34
2015
Q4
$57.8M Buy
2,374,797
+156,599
+7% +$3.81M 1.76% 22
2015
Q3
$39.4M Buy
2,218,198
+366,634
+20% +$6.5M 1.11% 34
2015
Q2
$32.7M Buy
1,851,564
+1,616,119
+686% +$28.5M 0.83% 43
2015
Q1
$7.38M Buy
+235,445
New +$7.38M 0.2% 76